RS Oncology Announces First Patient Dosed in Phase 2 Clinical Study
Feb 01, 2024
Posted by RS Oncology LLC
Massachusetts Biotechnology Council
Feb 01, 2024
Posted by RS Oncology LLC
Jan 30, 2024
Posted by ONTOFORCE, Inc.
Jan 24, 2024
Posted by Navigator Business Solutions